Risk Reduction: Clinical Trials

1 unknown. 1 Phase 3.

By phase and status

Phase	Trials	Status
Phase 3	1	Unknown 1

Follow Risk Reduction: new trials by email Literature Review of Risk Reduction trials Research Report on Risk Reduction

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Effect of Dapagliflozin Plus Low Dose Pioglitazone on Hospitalization Rate in Patients With HF and HFpEF Pioglitazone Plus dapaglifliozin, Placebo - Risk Reduction	Phase 3	Unknown	Hamad Medical Corporation	648	2019-03-01	2019-01-07

Narrower conditions

Risk Reduction Behavior (1)

Broader conditions

Behavior (1)

Interventions

Pioglitazone (1)

Sponsors

Hamad Medical Corporation (1)

Countries

Qatar (1)

Top investigators

Nidal Asaad, MD (1)

Results publications

PMID 1386652, PMID 14998615, PMID 15277411, PMID 16855265, PMID 18452784, PMID 19896746, PMID 23414743, PMID 25241351, PMID 25310928, PMID 25398313, PMID 25739882, PMID 26878357, PMID 27979896, PMID 28096223, PMID 28615237, PMID 4835750